Supplementary Table S1 from First-line Anlotinib plus Anthracyclines and Ifosfamide Followed by Anlotinib Maintenance in Advanced Soft-Tissue Sarcoma: A Phase II Single-Arm Trial

2026 Open access

Read full text

Authors: Jingyu Zhao, Zengjun Liu, Rui Wang, Heng Fu, Meng-yao Liu, Jing Xu, Xin Xu, Xiang-chun Fan, Wu Hu, Hui Zhang, Ni Xu, Ting Hao

+7 more

Hong-tu Yuan, Jian-bo Zhang, Minghuan Li, Lei Zhou, Chang-sheng Yang, Xiangying Wang, Dongyuan Zhu

DOI: 10.1158/1078-0432.31006821

Cited by: 0

Fields of Study & Subjects

Lung Cancer Research Studies PARP inhibition in cancer therapy Endometrial and Cervical Cancer Treatments